28 March 2023 | Q&A
However
Effectiveness of use of chloroquine/ hydroxychloroquine in COVID-19 case management: based on information
Scientists have suggested dozens of existing compounds for testing, but WHO is focusing on what it says are the four most promising therapies: an experimental
Reading time: Less than a minute (221 words) العربية
CNN — As the world’s heath experts race to find treatments – and eventually, a cure – for the novel coronavirus, two drugs have jumped to the front of the
The World Health Organization (WHO) said on Friday it was trying to get access to biggest functioning hospital in Gaza, the Nasser Hospital, following an Israeli
Just over 2 months from the reports of the first case in Wuhan, China, the widespread and increasing number of individuals infected forced the World Health
The World Health Organization and member countries in South-East Asia Region are prioritizing enhancing field epidemiology workforce as part of strengthening
In no event shall the World Health Organization be liable for damages arising from its use
Results: We included six articles (one narrative letter, one in-vitro study, one editorial, expert Treating malaria
Chloroquine, along with hydroxychloroquine, was an early experimental treatment for COVID-19
Chloroquine and hydroxychloroquine are anti-malarial medications also used against some auto-immune diseases
Governance
World Health Organization
Despite the intensification of resistance during the last 2 decades, chloroquine remains in 2000 the first-line treatment for malaria in most of these countries
The current versions, updated in July 2023, are the 23 rd Essential The WHO Global Malaria Programme (GMP) is responsible for coordinating WHO's global efforts to control and eliminate malaria
The search was based on keywords: antiviral drugs, chloroquine, hydroxychloroquine, COVID-19, COVID-19 treatment modalities, and
American scientists have begun a trial to see if chloroquine will help treat coronavirus
Patients received supervised antimalarial treatment and the primary efficacy end point was the clinical T he World Health Organization said Wednesday that it would launch a multiarm, multicountry clinical trial for potential coronavirus therapies, and the antimalarial drug chloroquine